The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer
โ Scribed by Nobuaki Otsuka; Masao Fukunaga; Teruki Sone; Masaya Yoneda; Noriaki Saito; Hiroyoshi Tanaka; Tatsushi Tomomitsu; Shinichi Yanagimoto; Akira Muranaka; Rikushi Morita
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 455 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
โฆ Synopsis
We used a combination of bone and bone-marrow scintigraphy to study 25 patients with prostatic cancer. Of the 18 cases whose 99mTc-methylene diphosphonate (MDP) bone scans showed hot spots in the lower lumbar region of the spine and/or the pelvic bone, 8 had normal bone-marrow scintigrams. These 8 patients were subsequently shown to have senile, degenerative changes of the spine. On the other hand, in 9 of the 10 patients whose bone-marrow scintigrams showed accumulation defects, follow-up study and characteristic X-ray findings confirmed the presence of metastases. In all 6 cases with extensive bone metastases shown by 99mTc-MDP bone scintigraphy, 99mTc-sulphur-colloid bone-marrow scintigraphy showed multiple accumulation defects. In conclusion, bone-marrow scintigraphy was found to be useful in distinguishing metastatic lesions from benign degenerative changes in the cases with suspected bone involvement, as well as in evaluating equivocal lesions in the pelvis.
๐ SIMILAR VOLUMES
## Abstract Prostate cancer (PCa) epithelial cells require a number of factors to facilitate their establishment and growth at a distant site of metastasis. Their ability to adapt to their microenvironment, proliferate and recruit an underlying stroma is integral to the survival and growth of the m
Prognosis in Ewing's sarcoma is inversely related to the extent of the disease at the time of presentation. The most common sites of metastases are the lungs and skeleton. Bone marrow metastases may be present but clinically silent. We report the use of Technetium Vc)-!?9m bone marrow scintigraphy t
## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCRโbased fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro